Nucleic Acid-Guided Nucleases (2017)

Manus Inscripta, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 15/632,001, filed Jun 23, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 9,982,279	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Term ends Jun 23, 2037 · High confidence	Manus Inscripta, Inc.	In force	Term ends Jun 23, 2037	Term ends Jun 23, 2037	High confidence
US 10,337,028	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Term ends Jun 23, 2037 · High confidence	Manus Inscripta, Inc.	In force	Term ends Jun 23, 2037	Term ends Jun 23, 2037	High confidence
US 11,408,012	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Term ends Jun 23, 2037 · Medium confidence	Manus Inscripta, Inc.	In force	Term ends Jun 23, 2037	Term ends Jun 23, 2037	Medium confidence
US 12,180,502	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Ends no later than Jun 23, 2037 · Medium confidence	Manus Inscripta, Inc.	In force	Ends no later than Jun 23, 2037	Ends no later than Jun 23, 2037	Medium confidence
US 11,697,826	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. In force Ends no later than Apr 27, 2040 · Medium confidence	Manus Inscripta, Inc.	In force	Ends no later than Apr 27, 2040	Ends no later than Apr 27, 2040	Medium confidence
Application 18/953,294	Nucleic Acid-Guided Nucleases Manus Inscripta, Inc. Pending Not granted	Manus Inscripta, Inc.	Pending	Not granted	not computed

6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

5 of these are in force and held by Manus Inscripta, Inc..

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.